Search -

Displaying 601 - 618 of 618

Sort: Relevancy | Date

News Daily News

Majority of US Patients Still Discharged on High-Dose Aspirin After Acute MI

Todd Neale

August 20, 2014

News Conference News ACC 2014

Perioperative Aspirin Increases Major Bleeding After Noncardiac Surgery

L.A. McKeown

March 31, 2014

News Daily News

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

Caitlin E. Cox

October 23, 2013

News Conference News ESC 2013

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Yael L. Maxwell

September 01, 2013

News Daily News

JAMA Review Tackles Intricacies of Medical Therapy After PCI

Caitlin E. Cox

July 11, 2013

News Daily News

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

Caitlin E. Cox

June 20, 2013

News Daily News

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Jason Kahn

January 22, 2013

News Daily News

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

L.A. McKeown

December 19, 2012

News Daily News

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

November 28, 2012

News Daily News

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

L.A. McKeown

August 09, 2012

News Daily News

CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events

L.A. McKeown

June 01, 2012

Presentation GI2 2012

Dual Antiplatelet Therapy Post PCI: Challenging the Guidelines

Presenter: Fausto Feres

April 13, 2012

News Daily News

New PLATO Analysis: Aspirin Dose May Explain Discordant North American Outcomes

Caitlin E. Cox

March 06, 2012

News Daily News

Six Months Sufficient for Dual Antiplatelet Therapy

Jason Kahn

October 17, 2011

News Conference News

Long-term Antiplatelet Therapy: All Risk, No Benefit

August 30, 2011

News Daily News

Late Aspirin Use Before CABG Does Not Increase Ischemic Events

Jason Kahn

February 02, 2011

News Daily News

JUPITER: Rosuvastatin Cuts Heart Risk, Even In LDL-Normal Patients

November 11, 2008

CME

Advertisement

Majority of US Patients Still Discharged on High-Dose Aspirin After Acute MI

Perioperative Aspirin Increases Major Bleeding After Noncardiac Surgery

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

JAMA Review Tackles Intricacies of Medical Therapy After PCI

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events

Dual Antiplatelet Therapy Post PCI: Challenging the Guidelines

New PLATO Analysis: Aspirin Dose May Explain Discordant North American Outcomes

Six Months Sufficient for Dual Antiplatelet Therapy

Long-term Antiplatelet Therapy: All Risk, No Benefit

Late Aspirin Use Before CABG Does Not Increase Ischemic Events

JUPITER: Rosuvastatin Cuts Heart Risk, Even In LDL-Normal Patients

Optimizing the Duration of DAPT following PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content